The Venture Codex Logo

The Venture Codex

Overview

Clinical-stage biopharmaceutical company targeting cancer resistance.

Total Raised

$103 M

Rounds

2

Links

Verticals

Biopharma
Biotechnology
Health Care
Pharmaceutical
Therapeutics

Investment History

  1. Series C

    Feb 2018

    $50M

  2. Series B

    Dec 2015

    $53M

Team

Jacob Chacko

Chief Executive Officer

Scott Lowe

Founder

Charles Sawyers

Founder

Pratik Multani

Chief Medical Officer